Latest Ratios: P/E Ratio 16.0x · EV/EBITDA 13.2x · ROE 12.6%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $11.1B | $8.8B | $5.5B | $4.1B | $4.1B | $5.2B | $3.3B | $3.4B | $3.0B | $3.6B | $3.8B |
| Enterprise Value | $14.0B | $11.6B | $-27864980 | $2.0B | $5.0B | $-574158820 | $2.4B | $3.6B | $2.9B | $3.2B | $4.6B |
| P/E Ratio → | 15.99 | 12.60 | 12.55 | 11.64 | 9.43 | 14.66 | 11.63 | 13.84 | 15.51 | 14.50 | 23.95 |
| P/S Ratio | 2.50 | 1.98 | 2.10 | 1.82 | 2.57 | 4.16 | 2.57 | 2.76 | 2.84 | 3.66 | 4.37 |
| P/B Ratio | 1.45 | 1.14 | 1.60 | 1.31 | 1.53 | 1.64 | 1.11 | 1.29 | 1.36 | 1.64 | 1.94 |
| P/FCF | 11.37 | 8.99 | 27.53 | 9.14 | 5.67 | 10.34 | 10.64 | 12.59 | 12.76 | 12.36 | 15.47 |
| P/OCF | 10.83 | 8.57 | 24.58 | 8.62 | 5.29 | 9.68 | 8.93 | 9.91 | 10.26 | 10.98 | 12.82 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.62 | -0.01 | 0.88 | 3.16 | -0.46 | 1.84 | 2.98 | 2.75 | 3.25 | 5.29 |
| EV / EBITDA | 13.17 | 10.98 | -0.05 | 4.10 | 8.52 | -1.18 | 5.92 | 10.63 | 10.63 | 10.92 | 18.16 |
| EV / EBIT | 15.52 | 12.94 | -0.05 | 4.67 | 9.39 | -1.34 | 7.02 | 12.72 | 13.16 | 13.45 | 23.14 |
| EV / FCF | — | 11.90 | -0.14 | 4.42 | 6.96 | -1.15 | 7.59 | 13.59 | 12.38 | 10.96 | 18.71 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.4% | 54.4% | 53.3% | 57.2% | 83.5% | 94.7% | 84.0% | 81.6% | 82.0% | 89.9% | 93.1% |
| Operating Margin | 20.3% | 20.3% | 20.5% | 18.8% | 33.6% | 34.5% | 26.2% | 23.4% | 20.9% | 24.1% | 22.9% |
| Net Profit Margin | 15.8% | 15.8% | 16.7% | 15.6% | 27.3% | 28.4% | 22.1% | 20.0% | 18.3% | 25.2% | 18.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 12.6% | 12.6% | 13.4% | 12.1% | 14.9% | 11.5% | 10.2% | 10.1% | 8.9% | 11.9% | 8.2% |
| ROA | 1.1% | 1.1% | 0.9% | 0.8% | 1.1% | 0.9% | 1.0% | 1.0% | 0.9% | 1.2% | 0.8% |
| ROIC | 7.5% | 7.5% | 6.2% | 5.3% | 6.7% | 5.3% | 5.0% | 5.1% | 4.6% | 4.8% | 3.9% |
| ROCE | 14.4% | 14.4% | 12.0% | 10.4% | 15.2% | 12.2% | 10.8% | 11.0% | 9.6% | 10.8% | 9.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.49 | 0.49 | 0.86 | 1.13 | 0.98 | 1.12 | 0.86 | 0.75 | 0.72 | 0.61 | 0.99 |
| Debt / EBITDA | 3.58 | 3.58 | 5.04 | 7.29 | 4.44 | 7.24 | 6.44 | 5.75 | 5.79 | 4.60 | 7.64 |
| Net Debt / Equity | — | 0.37 | -1.61 | -0.68 | 0.35 | -1.83 | -0.32 | 0.10 | -0.04 | -0.19 | 0.41 |
| Net Debt / EBITDA | 2.69 | 2.69 | -9.37 | -4.38 | 1.58 | -11.85 | -2.38 | 0.78 | -0.33 | -1.39 | 3.14 |
| Debt / FCF | — | 2.91 | -27.67 | -4.72 | 1.29 | -11.48 | -3.05 | 1.00 | -0.38 | -1.39 | 3.24 |
| Interest Coverage | 0.60 | 0.60 | 0.46 | 0.46 | 2.38 | 9.33 | 4.39 | 1.49 | 1.84 | 4.08 | 7.17 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.01 | 0.01 | 0.36 | 0.34 | 0.26 | 0.55 | 0.44 | 0.39 | 0.40 | 0.42 | 0.42 |
| Quick Ratio | 0.01 | 0.01 | 0.36 | 0.34 | 0.26 | 0.55 | 0.44 | 0.39 | 0.40 | 0.42 | 0.42 |
| Cash Ratio | 0.01 | 0.01 | 0.19 | 0.14 | 0.05 | 0.24 | 0.12 | 0.07 | 0.08 | 0.09 | 0.06 |
| Asset Turnover | — | 0.06 | 0.05 | 0.05 | 0.04 | 0.03 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.2% | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | 19.3% | 19.3% | 17.5% | 21.2% | 16.7% | 18.9% | 21.0% | 24.4% | 29.8% | 21.0% | 30.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 6.3% | 7.9% | 8.0% | 8.6% | 10.6% | 6.8% | 8.6% | 7.2% | 6.4% | 6.9% | 4.2% |
| FCF Yield | 8.8% | 11.1% | 3.6% | 10.9% | 17.6% | 9.7% | 9.4% | 7.9% | 7.8% | 8.1% | 6.5% |
| Buyback Yield | 1.2% | — | — | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 2.4% | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $76M | $49M | $49M | $49M | $49M | $48M | $49M | $50M | $50M | $49M |
M&A integration and margin compression
With a P/B ratio of 1.44 as of the most recent quarter, UMBF trades at a valuation that appears to discount its specialized institutional fee-based businesses, likely due to the market's struggle to reconcile its high-growth healthcare payments segment with the mature, spread-dependent regional banking operations.
The current valuation multiple suggests that investors are not yet fully pricing in the potential for margin expansion from the HSA platform, instead focusing on the immediate integration risks of the Heartland acquisition. This valuation gap warrants further investigation into whether the market views UMBF as a premium franchise or merely a commodity balance sheet burdened by recent inorganic expansion.
Based on reported financial data, UMBF's ROE has remained constrained in the low single digits, specifically 3.4% in 2026Q1, indicating that the bank's profitability is currently pressured by the dilutive impact of recent acquisitions and the associated overhead costs required to integrate the expanded operational footprint.
The decomposition of ROE suggests that the bank's reliance on non-interest income is a critical stabilizer, yet the current NIM compression to 0.7% significantly offsets these gains. Investors should monitor whether the bank can improve asset utilization as the Heartland integration matures, as current profitability levels appear to be significantly below historical norms.
According to quarterly regulatory filings, UMBF's efficiency ratio reached 47.0% in 2026Q1, a notable departure from the 30-40% range observed in prior periods, which suggests that the bank is currently absorbing significant overhead costs related to the integration of its expanded operational footprint and complex business model.
The compression of NIM to 0.7% indicates that the rapid expansion of the balance sheet has not yet translated into improved yield spreads, likely due to the immediate funding costs associated with recent acquisitions. This trend suggests that management faces a difficult path toward restoring operating leverage until the cost synergies from the Heartland deal are fully realized.
As reported in recent financial statements, UMBF's equity-to-assets ratio stood at 0.11 in 2026Q1, showing a modest improvement from the 0.07 level observed in 2024, which suggests that management is prioritizing capital preservation to support the integration of recent large-scale acquisitions while maintaining regulatory compliance.
The bank's ability to maintain these capital levels despite significant inorganic growth indicates a conservative approach to capital allocation. However, the large investment securities portfolio remains a potential source of volatility for book value, and investors should monitor how AOCI impacts the bank's tangible capital position in future periods.
The P/E ratio is frequently misapplied to UMBF, as it obscures the significant impact of non-recurring integration costs and provision volatility, which can create artificial fluctuations in earnings that do not reflect the underlying health of the bank's core institutional and commercial banking franchises.
Investors should instead prioritize P/TBV and ROTCE to better assess the bank's long-term value creation, as these metrics are less sensitive to the accounting noise generated by large-scale M&A activity. Relying on P/E in this context may lead to an inaccurate assessment of the bank's true earnings power during this period of structural transition.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying UMBF stock.
UMB Financial Corporation's current P/E ratio is 16.0x. The historical average is 20.6x. This places it at the 47th percentile of its historical range.
UMB Financial Corporation's current EV/EBITDA is 13.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.2x.
UMB Financial Corporation's return on equity (ROE) is 12.6%. The historical average is 9.5%.
Based on historical data, UMB Financial Corporation is trading at a P/E of 16.0x. This is at the 47th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
UMB Financial Corporation's current dividend yield is 1.21% with a payout ratio of 19.3%.
UMB Financial Corporation has 54.4% gross margin and 20.3% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
UMB Financial Corporation's Debt/EBITDA ratio is 3.6x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.